Pharmaceutical

Image

Global Veterinary Medicine Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Veterinary Medicine Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 24.97 Billion
Diagram Market Size (Forecast Year) USD 42.59 Billion
Diagram CAGR %

Global Veterinary Medicine Market, By Product (Biologics, Pharmaceuticals, Medicated Feed Additives), Animal Type (Production, Companion), Route of Administration (Oral, Parenteral, Others), End-User (Reference Laboratories, Point-of-Care Testing/In-House Testing, Veterinary Hospitals and Clinics, Others) – Industry Trends and Forecast to 2030.

Veterinary Medicine Market Analysis and Size

Animals like humans are vulnerable to many diseases such as bacteria, parasites, fungi, and viruses. Veterinary medicine aids agricultural animals and pets live longer and healthier lives. Growing the life expectancy of pets needs a better diet and the development of healthcare facilities. The increasing number of pets leads to a rise in chronic diseases.

Data Bridge Market Research analyses a growth rate in the veterinary medicine market in the forecast period 2023-2030. The expected CAGR of veterinary medicine market is tend to be around 6.90% in the mentioned forecast period. The market was valued at USD 24.97 billion in 2022 and would grow to USD 42.59 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Veterinary Medicine Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product (Biologics, Pharmaceuticals, Medicated Feed Additives), Animal Type (Production, Companion), Route of Administration (Oral, Parenteral, Others), End-User (Reference Laboratories, Point-of-Care Testing/In-House Testing, Veterinary Hospitals and Clinics, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim International GmbH. (Germany), Vetoquinol (France), Zoetis (U.S.), Ceva (France),  Cargill, Incorporated (U.S.), Nutreco (Netherlands), Virbac (France), Kindred Biosciences, Inc. (U.S.), NEOGEN Corporation (U.S.), Hester Biosciences Limited. (India), ADM (U.S.), Norbrook (U.K.), Dechra Pharmaceuticals PLC (U.K.), Evonik Industries AG (Germany)

Market Opportunities

  • Increasing Rate of Pet Owners

Market Definition

Veterinary medicine includes drugs such as anti-infectives and parasiticides that are provided to animals orally. Vaccines are also used in veterinary medicine to help immunity in animals against viral diseases such as equine influenza (EIV) and parainfluenza 3-respiratory syncytial virus. Medicated feed additives are mixed with animal feed to produce medicinal benefits in animals. Veterinary medicine is also used in a number of species, which includes companion animals such as dogs and cats along with livestock animals including cattle, pigs, and chickens

Veterinary Medicine Market Dynamics

Drivers

  • Rising demand for pet insurance policies

The increasing use of pet health insurance to pay for veterinarian services in several industrialized countries is anticipated to boost the market growth. Canada, the U.K., and Sweden all have a flourishing pet health insurance sector. The wide use of pet health insurance has increased intensely in China. The increasing awareness and wide understanding of pet health and the increasing popularity of pets are two important parts that have aided in the adoption of pet healthcare insurance.

  • Rising occurrences of zoonotic diseases among livestock animals

The rise in occurrences of zoonotic diseases among livestock animals will increase the numerous opportunities for the market's growth and influence market dynamics. The increased occurrence and financial burden of zoonotic illnesses among livestock animals boosted the livestock animals sector to occupy more than 63 % of the animal pharmaceuticals market share in the year 2020. Furthermore, bacterial parasites thrive by preying on farm animals, that causes huge sickness and financial hardship.

Opportunities

  • Increasing Rate of Pet Owners

A major increase in the number of pet owners is boosting the need for better treatment options for companion animals, resulting in increased health expenditure on pets. As per the American Pet Products Association, the total spending in the U.S. pet industry rise to USD 103.6 billion in 2020 from USD 97.1 billion in 2019, and it is assessed to reach more than USD 109.6 billion in 2022.Furthermore, around 67% of households in the U.S. owned a pet, that is equal to approximately 84.9 million homes in 2020.

Restraints/Challenges

  • High Cost of Treatment

The high cost of veterinary medicines are increasing with each passing day. The cost is quite high and thus it is limiting the market growth.

This veterinary medicine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary medicine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2020, Elanco acquired Bayer's Animal Health Business to expand its scale and capabilities, positioning it as a long-term leader in the lucrative and long-lasting animal health business

Global Veterinary Medicine Market Scope

The veterinary medicine market is segmented on the basis of product, animal type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

Animal Type

  • Production
  • Companion

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Reference Laboratories
  • Point-of-Care Testing/In-House Testing
  • Veterinary Hospitals and Clinics
  • Others

Veterinary Medicine Regional Analysis/Insights

The veterinary medicine market is analyzed and market size insights and trends are provided by product, animal type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the veterinary medicine market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the forecast period because of the wide presence of major market players and well-developed healthcare infrastructure in this region. In addition to this, the incidence of favourable government policies and growing initiatives to improve animal health will further propel the market's growth rate in this region.

Asia-Pacific is considered to grow over the coming years because of the wide expansion of manufacturing facilities and vaccination for livestock animals.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Global Veterinary Medicine Share Analysis

The veterinary medicine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to veterinary medicine market

Key players operating in the veterinary medicine market include:

  • Merck & Co., Inc. (U.S.)
  • Bayer AG (Germany)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Vetoquinol (France)
  • Zoetis (U.S.)
  • Ceva (France)
  • Cargill, Incorporated (U.S.)
  • Nutreco (Netherlands
  • Virbac (France)
  • Kindred Biosciences, Inc. (U.S.)
  • NEOGEN Corporation (U.S.)
  • Hester Biosciences Limited. (India)
  • ADM (U.S.)
  • Norbrook (U.K.)
  • Dechra Pharmaceuticals PLC (U.K.)
  • Evonik Industries AG (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The veterinary medicine market size will be worth USD 42.59 billion by 2030.
The growth rate of the veterinary medicine market is 6.90% in the forecast by 2030.
Product, animal type, route of administration, distribution channel, and end-user are the factors on which the veterinary medicine market research is based.
Major companies in the veterinary medicine market are Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim International GmbH. (Germany), Vetoquinol (France), Zoetis (U.S.), Ceva (France), Cargill, Incorporated (U.S.), Nutreco (Netherlands), Virbac (France), Kindred Biosciences, Inc. (U.S.), NEOGEN Corporation (U.S.), Hester Biosciences Limited. (India), ADM (U.S.), Norbrook (U.K.), Dechra Pharmaceuticals PLC (U.K.), Evonik Industries AG (Germany).
Rising demand for pet insurance policies & Rising occurrences of zoonotic diseases among livestock animals are the growth drivers of the veterinary medicine market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials